Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Arch Dis Child Fetal Neonatal Ed. 2021 Jan 21;106(4):446–455. doi: 10.1136/archdischild-2020-319705
Indication Catecholamine-resistant systemic hypotension
Refractory pulmonary hypertension not responsive to inhaled nitric oxide
Dose Acute crisis: 1 mg/kg/dose q 6 h
Maintenance: 1 mg/kg/day in divided doses
Severe PPHN not due to infection – 4 mg/kg/dose x 1 followed by 1 mg/kg q 6h x 4 doses followed by maintenance
Precautions Occult infection – fungal, viral (herpes simplex, CMV etc.,), bacterial can be exacerbated with steroid therapy
Contraindications Known or suspected infection
Class of Recommendation Class IIb – Usefulness/efficacy is less well established by evidence/opinion. May be considered
Level of Evidence C – Consensus of opinion of the experts and/or small studies, retrospective studies, registries